ban_l.gif, 1 kB ban_r.gif, 5 kB
Monday, 6th September 2010 .: Pharma Tech Mag
feed image
feed image
feed image

Pharma Tech Mag

Pharmaceutical Technology Magazine

A publication providing practical information on pharmaceutical manufacturing. Content focuses on applied R&D technology, process control and computer-integrated manufacturing, biotechnology and technical management.

BioProcess Containers
Oxoid Cold filterable Tryptone Soya Broth (cfTSB) and Cold filterable Vegetable Peptone Broth (cfVPB) have been specially developed for media fill trials, and meets the increasing regulatory demands of aseptic process validations.
 
CPhI/ICSE booth invitation
Vetter is an independent international specialist in the aseptic filling of drug-delivery systems. Providing extensive experience with complex compounds, Vetter supports pharmaceutical and biotech clients from preclinical development through global market supply.
 
Genetic Identification and Characterization in less than 8 Hours
The DuPont Qualicon RiboPrinter® microbial characterization system provides the speed, accuracy and resolution needed to identify bacteria and compare them at the strain level characterization, all in less than 8 hours.
 
Air Sampler
Oxoid Air Sampler is robust, flexible and easy to use. It will take any 90 or 55mm plates and is designed to monitor microbiological air quality in controlled environments. The Oxoid Air Sampler uses impaction technology that is proven to given reliable and accurate results time after time.
 
Comply with ICH guidelines on impurities in new drug products!
The Agilent 2100 Bioanalyzer plus the Agilent High Sensitivity Protein 250 Kit automatically detects and quantifies protein impurities down to 0.05% — meeting ICH guideline Q3B(R2)!
 
Syloid®FP silica excipients — more than just Silica
Silica, silicon dioxide (USP) or colloidal silica (EP) is generally only mentioned in literature today as an excipient to improve flow properties and in some cases as a hydrophilic lubricant.
 
Media fill trials
Oxoid Cold filterable Tryptone Soya Broth (cfTSB) has been specially developed for media fill trials, and meets the increasing regulatory demands on aseptic process validations.
 
The new HygroPalm23-AW-SET — now with 15% discount!
The HygroPalm AW sets are the perfect solution for on-site measurements. They are supplied in a tough, lightweight ABS carry case and include everything needed for measurement and calibration.
 
EMA reviews safety of GSK vaccine
The European Medicines Agency (EMA) has launched a review of GlaxoSmithKline's pandemic influenza vaccine Pandemrix to investigate whether there is a link between vaccination and cases of narcolepsy, a rare sleep disorder.
 
Regulatory Roundup: FDA Provides Information on Advisory Committees, Announces Public Meetings, And More.
FDA Provides Information On Advisory Committees, Announces Public Meetings, And More.
 
Presidential Advisory Council Says Vaccine Production for Pandemic Preparedness Needs to Be Improved
The President's Council on Advisors on Science and Technology (PCAST), a group administered by the federal Office of Science and Technology Policy (OSTP), issued recommendations to improve the country's ability to accelerate vaccine production and delivery in the event of a pandemic flu outbreak.
 
Week of Aug. 30, 2010: Company and People Notes: Lonza Acquires Vivante; PPD Appoints VP of Quality Management; And More.
Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.
 
Genzyme Rejects Sanofi-Aventis's Acquisition Proposal
Genzyme (Cambridge, MA) confirmed that it had received sanofi-aventis's (Paris) proposal to acquire all of its outstanding shares for $69 each.
 
Secretary of State Clinton Outlines US Role in Global Health
Secretary of State Hillary Clinton details the progress and future direction of the US role in the Global Health Initiative.
 
News
Pharma struggling with social media; Opportunities in the OTC market
 
Launching And Commercializing Biosimilars
Many hurdles lie between a biosimilar and success on the market. In particular, there are three main questions that companies will be asking themselves.
 
Continuous Processing: Is The Pharma Industry Finally Coming Round To The Idea?
Industry experts discuss the merits of continuous processing technology and explain why pharma manufacturers should realize the benefits these technologies offer.
 
Approach social media with caution?
No one can deny the power of social media; it has revolutionised communication and empowered consumers, creating a medium that allows the free flow of information with no authority to control it.
 
Project Managers Wanted
Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
 
Successfully managing CMO-client relationships
Contract manufacturers must view their relationships with clients as a partnership, which lasts beyond the fulfillment of a particular project, and not simply as a single transaction.
 
How To Identify The Right Outsourcing Partner In Asia–Pacific
How to find the right partner in Asia–Pacific is a very complex question and there is no uniform answer.
 
Behind The Scenes Of Pharma Mergers And Acquisitions
Despite the poor economic climate, large-scale mergers and acquisitions in the pharmaceutical industry struck back with a vengeance in 2009.
 
Biosimilars: Perception, cost And The Impact On Biotech Innovation
In light of the impressive size and predicted growth of the market, there has been a rising interest in the development of biosimilars.
 
The Effect Of The Financial Crisis On Outsourcing
The economic crisis has affected outsourcing providers in several ways.
 
Outsourcing: The Indian Perspective
The turning point for India as a centre for outsourcing came in 2005 with the Patents (Amendment) Act